These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33942851)

  • 1. The role of microRNAs on doxorubicin drug resistance in breast cancer.
    Jamialahmadi K; Zahedipour F; Karimi G
    J Pharm Pharmacol; 2021 Jul; 73(8):997-1006. PubMed ID: 33942851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance.
    Gomes BC; Honrado M; Armada A; Viveiros M; Rueff J; Rodrigues AS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
    Chu S; Liu G; Xia P; Chen G; Shi F; Yi T; Zhou H
    Oncol Rep; 2017 Oct; 38(4):2401-2407. PubMed ID: 28765915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
    Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
    J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells.
    Ponnusamy L; Mahalingaiah PKS; Singh KP
    Eur J Pharm Sci; 2017 Jun; 104():424-433. PubMed ID: 28455002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
    Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
    Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
    Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
    Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells.
    Takwi AA; Wang YM; Wu J; Michaelis M; Cinatl J; Chen T
    Oncogene; 2014 Jul; 33(28):3717-29. PubMed ID: 23934188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
    Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
    Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.
    Kovalchuk O; Filkowski J; Meservy J; Ilnytskyy Y; Tryndyak VP; Chekhun VF; Pogribny IP
    Mol Cancer Ther; 2008 Jul; 7(7):2152-9. PubMed ID: 18645025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
    Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
    Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.
    Torki Z; Ghavi D; Hashemi S; Rahmati Y; Rahmanpour D; Pornour M; Alivand MR
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):771-793. PubMed ID: 34510251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.
    Calcagno AM; Fostel JM; To KK; Salcido CD; Martin SE; Chewning KJ; Wu CP; Varticovski L; Bates SE; Caplen NJ; Ambudkar SV
    Br J Cancer; 2008 May; 98(9):1515-24. PubMed ID: 18382425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters.
    Shivhare S; Das A
    Mol Biol Rep; 2023 Jan; 50(1):215-225. PubMed ID: 36319789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
    Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
    Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.